# Residual tumor volume and survival after CCNU/TMZ in GBM

An episode of [Neuro-Oncology: The Podcast](https://invisiblenetwork.ai/podcast/1541259930), 24 Nov 2024, 13 min.

Audio: https://traffic.libsyn.com/secure/soc-neuro-onc/nop-93.mp3?dest-id=2339594

Dr. Iyad Alnahhas interviews Drs. Thomas Zeyen and Johannes Weller about their recent manuscript entitled: "Quantitative assessment of residual tumor is a strong and independent predictor of survival in methylated glioblastoma following radiochemotherapy with CCNU/TMZ", published online in Neuro-Oncology in October 2024.

Shows are listed from Apple Podcasts' charts and directory, and Podcast Index where it is used. Every show and episode belongs to its publisher and plays from the publisher's own feed; this site hosts none of them.